Sujatha Nallapareddy
- Molecular Biology
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Cancer Research
- Pathology and Forensic Medicine
- Co-authors
- Wells A. MessersmithHoward A. BurrisDonna S. CoxDouglas J. DeMariniLeslie A. FecherShannon R. MorrisKeith T. FlahertyMichael S. Gordon
- Topics
- Colorectal Cancer Treatments and Studies (8 papers)Melanoma and MAPK Pathways (5 papers)Pancreatic and Hepatic Oncology Research (4 papers)
- Partner nations
- United StatesSpainChina
In The Last Decade
Sujatha Nallapareddy
16 papers receiving 777 citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Molecular Biology 509
- Oncology 440
- Pulmonary and Respiratory Medicine 141
- Cancer Research 122
- Pathology and Forensic Medicine 103
Countries citing papers authored by Sujatha Nallapareddy
This map shows the geographic impact of Sujatha Nallapareddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujatha Nallapareddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujatha Nallapareddy more than expected).
Fields of papers citing papers by Sujatha Nallapareddy
This network shows the impact of papers produced by Sujatha Nallapareddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujatha Nallapareddy. The network helps show where Sujatha Nallapareddy may publish in the future.
Co-authorship network of co-authors of Sujatha Nallapareddy
This figure shows the co-authorship network connecting the top 25 collaborators of Sujatha Nallapareddy. A scholar is included among the top collaborators of Sujatha Nallapareddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sujatha Nallapareddy. Sujatha Nallapareddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trialbreakdown → | 424 |
| 2 | 13 | |
| 3 | 37 | |
| 4 | 63 | |
| 5 | 7 | |
| 6 | 39 | |
| 7 | 92 | |
| 8 | 17 | |
| 9 | 2 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 13 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | Chemoradiation is a tolerable therapy for older adults with esophageal cancer. | 19 |
| 16 | 60 |
About Sujatha Nallapareddy
Sujatha Nallapareddy is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 16 papers that have together received 790 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Melanoma and MAPK Pathways (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (440 citations), Cancer Research (122 citations) and Molecular Biology (509 citations). Sujatha Nallapareddy has collaborated with scholars based in United States, Spain and China. Frequent co-authors include Wells A. Messersmith, Howard A. Burris, Donna S. Cox, Douglas J. DeMarini, Leslie A. Fecher, Shannon R. Morris, Keith T. Flaherty, Michael S. Gordon, Gerald S. Falchook and Ngocdiep T. Le. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.